nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0527	0.0706	CbGbCtD
Toremifene—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0496	0.0664	CbGbCtD
Toremifene—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0496	0.0664	CbGbCtD
Toremifene—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0448	0.06	CbGbCtD
Toremifene—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0434	0.0581	CbGbCtD
Toremifene—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0392	0.0525	CbGbCtD
Toremifene—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0376	0.0503	CbGbCtD
Toremifene—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.034	0.0455	CbGbCtD
Toremifene—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0338	0.0453	CbGbCtD
Toremifene—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0329	0.044	CbGbCtD
Toremifene—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0297	0.0398	CbGbCtD
Toremifene—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0297	0.0398	CbGbCtD
Toremifene—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0285	0.0381	CbGbCtD
Toremifene—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0276	0.037	CbGbCtD
Toremifene—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.026	0.0348	CbGbCtD
Toremifene—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.026	0.0348	CbGbCtD
Toremifene—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0235	0.0315	CbGbCtD
Toremifene—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0235	0.0315	CbGbCtD
Toremifene—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.022	0.0295	CbGbCtD
Toremifene—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0203	0.0272	CbGbCtD
Toremifene—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0197	0.0264	CbGbCtD
Toremifene—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0178	0.0238	CbGbCtD
Toremifene—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0178	0.0238	CbGbCtD
Toremifene—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0171	0.0229	CbGbCtD
Toremifene—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000961	0.0774	CbGeAlD
Toremifene—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000696	0.056	CbGeAlD
Toremifene—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000493	0.0396	CbGeAlD
Toremifene—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.000486	0.0391	CbGeAlD
Toremifene—ESR1—digestive system—acquired immunodeficiency syndrome	0.00048	0.0386	CbGeAlD
Toremifene—ESR1—blood—acquired immunodeficiency syndrome	0.000457	0.0368	CbGeAlD
Toremifene—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000456	0.0367	CbGeAlD
Toremifene—ESR1—vagina—acquired immunodeficiency syndrome	0.000424	0.0341	CbGeAlD
Toremifene—ESR1—lung—acquired immunodeficiency syndrome	0.000401	0.0322	CbGeAlD
Toremifene—ESR1—nervous system—acquired immunodeficiency syndrome	0.000371	0.0298	CbGeAlD
Toremifene—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00037	0.0298	CbGeAlD
Toremifene—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.000365	0.00152	CcSEcCtD
Toremifene—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000365	0.00152	CcSEcCtD
Toremifene—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000365	0.0293	CbGeAlD
Toremifene—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000364	0.00151	CcSEcCtD
Toremifene—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.000363	0.00151	CcSEcCtD
Toremifene—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000361	0.0015	CcSEcCtD
Toremifene—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.00036	0.00149	CcSEcCtD
Toremifene—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00036	0.00149	CcSEcCtD
Toremifene—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00149	CcSEcCtD
Toremifene—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000358	0.00149	CcSEcCtD
Toremifene—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00148	CcSEcCtD
Toremifene—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000357	0.00148	CcSEcCtD
Toremifene—ESR1—central nervous system—acquired immunodeficiency syndrome	0.000357	0.0287	CbGeAlD
Toremifene—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000357	0.00148	CcSEcCtD
Toremifene—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000355	0.00147	CcSEcCtD
Toremifene—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000355	0.00147	CcSEcCtD
Toremifene—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000354	0.00147	CcSEcCtD
Toremifene—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000354	0.00147	CcSEcCtD
Toremifene—Constipation—Stavudine—acquired immunodeficiency syndrome	0.000354	0.00147	CcSEcCtD
Toremifene—Pain—Stavudine—acquired immunodeficiency syndrome	0.000354	0.00147	CcSEcCtD
Toremifene—Chills—Ritonavir—acquired immunodeficiency syndrome	0.000353	0.00147	CcSEcCtD
Toremifene—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000353	0.00147	CcSEcCtD
Toremifene—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000352	0.00146	CcSEcCtD
Toremifene—CYP1A2—blood—acquired immunodeficiency syndrome	0.000352	0.0283	CbGeAlD
Toremifene—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00146	CcSEcCtD
Toremifene—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000352	0.00146	CcSEcCtD
Toremifene—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000349	0.00145	CcSEcCtD
Toremifene—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000349	0.00145	CcSEcCtD
Toremifene—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000349	0.00145	CcSEcCtD
Toremifene—Pain—Abacavir—acquired immunodeficiency syndrome	0.000349	0.00145	CcSEcCtD
Toremifene—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000348	0.00145	CcSEcCtD
Toremifene—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000348	0.00144	CcSEcCtD
Toremifene—CYP1A1—blood—acquired immunodeficiency syndrome	0.000347	0.028	CbGeAlD
Toremifene—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000347	0.00144	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000347	0.00144	CcSEcCtD
Toremifene—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000345	0.00143	CcSEcCtD
Toremifene—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.00143	CcSEcCtD
Toremifene—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000343	0.00142	CcSEcCtD
Toremifene—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	0.000343	0.00142	CcSEcCtD
Toremifene—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000342	0.00142	CcSEcCtD
Toremifene—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00142	CcSEcCtD
Toremifene—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00034	0.00141	CcSEcCtD
Toremifene—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000337	0.0014	CcSEcCtD
Toremifene—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000335	0.00139	CcSEcCtD
Toremifene—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00139	CcSEcCtD
Toremifene—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000333	0.00138	CcSEcCtD
Toremifene—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000333	0.00138	CcSEcCtD
Toremifene—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.00138	CcSEcCtD
Toremifene—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.00138	CcSEcCtD
Toremifene—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00138	CcSEcCtD
Toremifene—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	0.00033	0.00137	CcSEcCtD
Toremifene—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00033	0.00137	CcSEcCtD
Toremifene—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00033	0.00137	CcSEcCtD
Toremifene—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000329	0.00137	CcSEcCtD
Toremifene—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000328	0.00136	CcSEcCtD
Toremifene—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000328	0.00136	CcSEcCtD
Toremifene—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000328	0.00136	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00136	CcSEcCtD
Toremifene—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000326	0.00135	CcSEcCtD
Toremifene—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000325	0.00135	CcSEcCtD
Toremifene—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000325	0.00135	CcSEcCtD
Toremifene—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000324	0.00135	CcSEcCtD
Toremifene—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00134	CcSEcCtD
Toremifene—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000323	0.00134	CcSEcCtD
Toremifene—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000322	0.0259	CbGeAlD
Toremifene—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000321	0.00133	CcSEcCtD
Toremifene—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000321	0.00133	CcSEcCtD
Toremifene—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000319	0.00133	CcSEcCtD
Toremifene—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.00133	CcSEcCtD
Toremifene—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000319	0.00132	CcSEcCtD
Toremifene—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.00131	CcSEcCtD
Toremifene—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000315	0.00131	CcSEcCtD
Toremifene—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000313	0.0013	CcSEcCtD
Toremifene—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000311	0.00129	CcSEcCtD
Toremifene—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000311	0.00129	CcSEcCtD
Toremifene—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00031	0.00129	CcSEcCtD
Toremifene—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00031	0.00129	CcSEcCtD
Toremifene—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.00031	0.00129	CcSEcCtD
Toremifene—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000309	0.00128	CcSEcCtD
Toremifene—CYP1A2—lung—acquired immunodeficiency syndrome	0.000309	0.0248	CbGeAlD
Toremifene—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00128	CcSEcCtD
Toremifene—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00128	CcSEcCtD
Toremifene—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000308	0.00128	CcSEcCtD
Toremifene—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000308	0.00128	CcSEcCtD
Toremifene—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000307	0.00128	CcSEcCtD
Toremifene—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00127	CcSEcCtD
Toremifene—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00127	CcSEcCtD
Toremifene—CYP1A1—lung—acquired immunodeficiency syndrome	0.000305	0.0245	CbGeAlD
Toremifene—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.00126	CcSEcCtD
Toremifene—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000303	0.00126	CcSEcCtD
Toremifene—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000303	0.00126	CcSEcCtD
Toremifene—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000303	0.00126	CcSEcCtD
Toremifene—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000302	0.00126	CcSEcCtD
Toremifene—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000301	0.00125	CcSEcCtD
Toremifene—Rash—Didanosine—acquired immunodeficiency syndrome	0.000301	0.00125	CcSEcCtD
Toremifene—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.0003	0.00125	CcSEcCtD
Toremifene—Headache—Didanosine—acquired immunodeficiency syndrome	0.000299	0.00124	CcSEcCtD
Toremifene—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000298	0.00124	CcSEcCtD
Toremifene—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000298	0.00124	CcSEcCtD
Toremifene—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000297	0.00123	CcSEcCtD
Toremifene—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000296	0.00123	CcSEcCtD
Toremifene—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000296	0.00123	CcSEcCtD
Toremifene—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00123	CcSEcCtD
Toremifene—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000295	0.00122	CcSEcCtD
Toremifene—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000294	0.00122	CcSEcCtD
Toremifene—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000294	0.00122	CcSEcCtD
Toremifene—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000293	0.00122	CcSEcCtD
Toremifene—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000293	0.00122	CcSEcCtD
Toremifene—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00121	CcSEcCtD
Toremifene—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.00121	CcSEcCtD
Toremifene—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000291	0.00121	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.0012	CcSEcCtD
Toremifene—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000289	0.0012	CcSEcCtD
Toremifene—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000288	0.0012	CcSEcCtD
Toremifene—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000288	0.0012	CcSEcCtD
Toremifene—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000288	0.0012	CcSEcCtD
Toremifene—Pain—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00119	CcSEcCtD
Toremifene—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00119	CcSEcCtD
Toremifene—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000286	0.00119	CcSEcCtD
Toremifene—ESR1—brain—acquired immunodeficiency syndrome	0.000284	0.0228	CbGeAlD
Toremifene—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000283	0.00118	CcSEcCtD
Toremifene—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00117	CcSEcCtD
Toremifene—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000282	0.0227	CbGeAlD
Toremifene—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000282	0.00117	CcSEcCtD
Toremifene—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00117	CcSEcCtD
Toremifene—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00117	CcSEcCtD
Toremifene—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00116	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00116	CcSEcCtD
Toremifene—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000275	0.00114	CcSEcCtD
Toremifene—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000275	0.00114	CcSEcCtD
Toremifene—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00114	CcSEcCtD
Toremifene—ESR1—lymph node—acquired immunodeficiency syndrome	0.000274	0.022	CbGeAlD
Toremifene—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00114	CcSEcCtD
Toremifene—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000274	0.00114	CcSEcCtD
Toremifene—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000274	0.00114	CcSEcCtD
Toremifene—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00113	CcSEcCtD
Toremifene—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000273	0.00113	CcSEcCtD
Toremifene—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000273	0.00113	CcSEcCtD
Toremifene—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00113	CcSEcCtD
Toremifene—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000272	0.0219	CbGeAlD
Toremifene—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—ABCB1—retina—acquired immunodeficiency syndrome	0.00027	0.0217	CbGeAlD
Toremifene—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00027	0.00112	CcSEcCtD
Toremifene—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00112	CcSEcCtD
Toremifene—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000269	0.00112	CcSEcCtD
Toremifene—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00111	CcSEcCtD
Toremifene—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000268	0.0215	CbGeAlD
Toremifene—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00111	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00111	CcSEcCtD
Toremifene—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.0011	CcSEcCtD
Toremifene—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000264	0.0011	CcSEcCtD
Toremifene—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.00109	CcSEcCtD
Toremifene—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000263	0.00109	CcSEcCtD
Toremifene—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00109	CcSEcCtD
Toremifene—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.00109	CcSEcCtD
Toremifene—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000262	0.00109	CcSEcCtD
Toremifene—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00109	CcSEcCtD
Toremifene—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00108	CcSEcCtD
Toremifene—Rash—Stavudine—acquired immunodeficiency syndrome	0.000261	0.00108	CcSEcCtD
Toremifene—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000261	0.00108	CcSEcCtD
Toremifene—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000261	0.00108	CcSEcCtD
Toremifene—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00108	CcSEcCtD
Toremifene—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00026	0.00108	CcSEcCtD
Toremifene—Headache—Stavudine—acquired immunodeficiency syndrome	0.000259	0.00108	CcSEcCtD
Toremifene—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000259	0.00108	CcSEcCtD
Toremifene—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00107	CcSEcCtD
Toremifene—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00107	CcSEcCtD
Toremifene—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000258	0.00107	CcSEcCtD
Toremifene—Rash—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00107	CcSEcCtD
Toremifene—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000257	0.00107	CcSEcCtD
Toremifene—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00107	CcSEcCtD
Toremifene—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00107	CcSEcCtD
Toremifene—Headache—Abacavir—acquired immunodeficiency syndrome	0.000255	0.00106	CcSEcCtD
Toremifene—CYP3A4—blood—acquired immunodeficiency syndrome	0.000255	0.0205	CbGeAlD
Toremifene—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000255	0.00106	CcSEcCtD
Toremifene—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000255	0.00106	CcSEcCtD
Toremifene—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000253	0.00105	CcSEcCtD
Toremifene—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00105	CcSEcCtD
Toremifene—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000251	0.00104	CcSEcCtD
Toremifene—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00104	CcSEcCtD
Toremifene—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.00104	CcSEcCtD
Toremifene—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00103	CcSEcCtD
Toremifene—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.00102	CcSEcCtD
Toremifene—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000246	0.00102	CcSEcCtD
Toremifene—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00102	CcSEcCtD
Toremifene—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00101	CcSEcCtD
Toremifene—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00101	CcSEcCtD
Toremifene—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00101	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.001	CcSEcCtD
Toremifene—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000241	0.001	CcSEcCtD
Toremifene—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00024	0.000997	CcSEcCtD
Toremifene—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00024	0.000997	CcSEcCtD
Toremifene—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000994	CcSEcCtD
Toremifene—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.000994	CcSEcCtD
Toremifene—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000238	0.000988	CcSEcCtD
Toremifene—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000237	0.000983	CcSEcCtD
Toremifene—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.000972	CcSEcCtD
Toremifene—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000965	CcSEcCtD
Toremifene—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000965	CcSEcCtD
Toremifene—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000232	0.000964	CcSEcCtD
Toremifene—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000956	CcSEcCtD
Toremifene—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000956	CcSEcCtD
Toremifene—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000229	0.000951	CcSEcCtD
Toremifene—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000229	0.00095	CcSEcCtD
Toremifene—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000942	CcSEcCtD
Toremifene—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000942	CcSEcCtD
Toremifene—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000227	0.000941	CcSEcCtD
Toremifene—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.000936	CcSEcCtD
Toremifene—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000224	0.000929	CcSEcCtD
Toremifene—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.000927	CcSEcCtD
Toremifene—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.000921	CcSEcCtD
Toremifene—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000221	0.00092	CcSEcCtD
Toremifene—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000221	0.000919	CcSEcCtD
Toremifene—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000912	CcSEcCtD
Toremifene—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000912	CcSEcCtD
Toremifene—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000901	CcSEcCtD
Toremifene—CYP1A1—brain—acquired immunodeficiency syndrome	0.000216	0.0173	CbGeAlD
Toremifene—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000214	0.000889	CcSEcCtD
Toremifene—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000888	CcSEcCtD
Toremifene—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000213	0.000884	CcSEcCtD
Toremifene—Rash—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000876	CcSEcCtD
Toremifene—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000875	CcSEcCtD
Toremifene—Headache—Indinavir—acquired immunodeficiency syndrome	0.00021	0.000871	CcSEcCtD
Toremifene—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000868	CcSEcCtD
Toremifene—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000208	0.0168	CbGeAlD
Toremifene—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000207	0.0167	CbGeAlD
Toremifene—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000835	CcSEcCtD
Toremifene—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000834	CcSEcCtD
Toremifene—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000831	CcSEcCtD
Toremifene—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000828	CcSEcCtD
Toremifene—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000199	0.016	CbGeAlD
Toremifene—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.000827	CcSEcCtD
Toremifene—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000826	CcSEcCtD
Toremifene—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000823	CcSEcCtD
Toremifene—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000822	CcSEcCtD
Toremifene—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000802	CcSEcCtD
Toremifene—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000799	CcSEcCtD
Toremifene—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000192	0.0154	CbGeAlD
Toremifene—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000792	CcSEcCtD
Toremifene—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000791	CcSEcCtD
Toremifene—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000791	CcSEcCtD
Toremifene—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000787	CcSEcCtD
Toremifene—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000189	0.0152	CbGeAlD
Toremifene—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.00078	CcSEcCtD
Toremifene—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000768	CcSEcCtD
Toremifene—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000765	CcSEcCtD
Toremifene—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000755	CcSEcCtD
Toremifene—ABCB1—blood—acquired immunodeficiency syndrome	0.00018	0.0145	CbGeAlD
Toremifene—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000746	CcSEcCtD
Toremifene—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000739	CcSEcCtD
Toremifene—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000739	CcSEcCtD
Toremifene—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000733	CcSEcCtD
Toremifene—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000732	CcSEcCtD
Toremifene—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000728	CcSEcCtD
Toremifene—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000175	0.0141	CbGeAlD
Toremifene—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000174	0.014	CbGeAlD
Toremifene—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000711	CcSEcCtD
Toremifene—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000705	CcSEcCtD
Toremifene—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000705	CcSEcCtD
Toremifene—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000704	CcSEcCtD
Toremifene—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000701	CcSEcCtD
Toremifene—ABCB1—vagina—acquired immunodeficiency syndrome	0.000167	0.0135	CbGeAlD
Toremifene—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.00069	CcSEcCtD
Toremifene—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000678	CcSEcCtD
Toremifene—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000673	CcSEcCtD
Toremifene—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000672	CcSEcCtD
Toremifene—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000668	CcSEcCtD
Toremifene—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000664	CcSEcCtD
Toremifene—ABCB1—lung—acquired immunodeficiency syndrome	0.000158	0.0127	CbGeAlD
Toremifene—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000634	CcSEcCtD
Toremifene—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000146	0.0118	CbGeAlD
Toremifene—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000141	0.0113	CbGeAlD
Toremifene—ABCB1—brain—acquired immunodeficiency syndrome	0.000112	0.00901	CbGeAlD
Toremifene—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000108	0.00871	CbGeAlD
